spacer
home > pmps > winter 2018 > customer centric
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Customer Centric

Major changes in the pharmaceutical and healthcare environments over the past 10 years have driven an urgent need to rethink how medicines are delivered to patients. The heyday of the pharma industry was in the 1980s and 1990s, when a range of blockbuster drugs secured continuous revenues and rapid growth for the major researchled drug makers. Pharma was then a blunt instrument aimed at treating a broad range of conditions, with often as little as a 20% success rate and trialand- error approach. If the first drug did not work, try another until some progress was seen in the patient.

This approach is no longer possible, nor is it acceptable to the healthcare industry or the patients. The information age and growing access to modern medicines around the world have increased expectations. Additionally, due to the complexity of an ageing population, drug patent expiries leading to collapsing revenues, and economic pressure from the payers of healthcare, pharma companies are now expected to demonstrate efficacy and costeffectiveness from day one.

The pharma industry has responded: massive restructuring activities have been undertaken to reduce costs, and advanced research in fields such as pharmacogenomics have opened the door to turn this blunt instrument into a precision tool.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Colin Reed is Marketing and Strategy Director at Amcor Flexibles Healthcare Europe, Middle East, and Africa. He has 19 years of experience in healthcare packaging and has held previous leadership positions in operations and marketing, including managing businesses in Asia-Pacific. Colin is a UK national and holds a Bachelor of Engineering degree and an MBA.
spacer
Colin Reed
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Serialization Installation at Tredegar Manufacturing Center of Excellence

PCI Pharma Services (PCI) is pleased to announce the installation and validation of its latest comprehensive Serialization system, located at its manufacturing Center of Excellence in Tredegar, UK.  The investment demonstrates PCIís continued investment in and expansion of market-leading Serialization capabilities. This latest installation increases PCIís Serialization capability to support clients in advance of implementation dates for the European Falsified Medicines Directive (EU FMD), as well as supply for the US and emerging markets, including countries such as China, Turkey, Brazil, Saudi Arabia and others.  PCIís system is compliant to all EU member country requirements for Serialization and specialized labeling, including application and integration of advanced Anticounterfeiting technologies.
More info >>

White Papers

Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test

Wickham Laboratories Limited

Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
More info >>

 
Industry Events

SMiís 9th Annual Biosimilars & Biobetters Conference

25-27 September 2018, Copthorne Tara Hotel, London, UK

Following the success of our previous events in both London and the US, Biosimilars and Biobetters UK 2018, SMi deliver a stellar speaker line-up and bring together a global audience of biosimilar experts to discuss the latest developments and future of the rapidly evolving and expanding biosimilars market.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement